Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Multivitamins, Supplements Fill Nutrient Gaps In American Diets – CRN Survey

This article was originally published in The Tan Sheet

  • News
  • Jessica Lake and Regina Lapierre

Executive Summary

Nearly half of adult Americans (46%) take multivitamins at least five days a week and 41% take a multivitamin daily, according to the results of a recent survey commissioned by the Council for Responsible Nutrition

You may also be interested in...



More Multivitamin Research Needed To Show Disease Prevention – NIH Panel

Members of an independent NIH panel evaluating the safety and effectiveness of multivitamin/minerals (MVMs) hope that a draft report containing their recommendations will spur action on research efforts for the supplement category

Multivitamins, Supplements Fill Nutrient Gaps In American Diets – CRN Survey

Nearly half of adult Americans (46%) take multivitamins at least five days a week and 41% take a multivitamin daily, according to the results of a recent survey commissioned by the Council for Responsible Nutrition

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS099562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By